Medical Center Pharmacy Inc. | |
2401 N Ocoee St, Cleveland, Tennessee 37311 | |
(423) 476-5547 |
Name | Medical Center Pharmacy Inc. |
---|---|
Organization Name | Medical Center Pharmacy Inc |
Location | 2401 N Ocoee St, Cleveland, Tennessee 37311 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (423) 476-5547 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In response to the crisis caused by milk adulterated with melamine that affected thousands of children in 2008, the International Dairy Federation and the International Organization for Standardization developed a technical specification/reviewed method : ISO/TS 15495 | IDF/RM 230:2010, Milk, milk products and infant formulae - Guidelines for the quantitative determination of melamine and cyanuric acid by LC-MS/MS.
A new study published in the Journal of Public Health has shown that the majority of people in the United Kingdom do not understand the connection between weight issues and cancer.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
Olaparib, a new type of experimental drug called a PARP inhibitor, has shown promising results against inherited forms of breast and ovarian cancer in two small clinical trials led by scientists at the Breakthrough Breast Cancer Research Unit at King's College London.
› Verified 1 days ago
NPI Number | 1033277447 |
Organization Name | MEDICAL CENTER PHARMACY INC |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 2401 N Ocoee St, Cleveland, TN 37311 |
Phone Number | 423-476-5547 |
News Archive
In response to the crisis caused by milk adulterated with melamine that affected thousands of children in 2008, the International Dairy Federation and the International Organization for Standardization developed a technical specification/reviewed method : ISO/TS 15495 | IDF/RM 230:2010, Milk, milk products and infant formulae - Guidelines for the quantitative determination of melamine and cyanuric acid by LC-MS/MS.
A new study published in the Journal of Public Health has shown that the majority of people in the United Kingdom do not understand the connection between weight issues and cancer.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
Olaparib, a new type of experimental drug called a PARP inhibitor, has shown promising results against inherited forms of breast and ovarian cancer in two small clinical trials led by scientists at the Breakthrough Breast Cancer Research Unit at King's College London.
› Verified 1 days ago
NPI Number | 1841364379 |
Organization Name | MEDICAL CENTER PHARMACY INC |
Doing Business As | MEDICAL CENTER PHARMACY |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 2401 N Ocoee St, Cleveland, TN 37311 |
Phone Number | 423-476-5547 |
News Archive
In response to the crisis caused by milk adulterated with melamine that affected thousands of children in 2008, the International Dairy Federation and the International Organization for Standardization developed a technical specification/reviewed method : ISO/TS 15495 | IDF/RM 230:2010, Milk, milk products and infant formulae - Guidelines for the quantitative determination of melamine and cyanuric acid by LC-MS/MS.
A new study published in the Journal of Public Health has shown that the majority of people in the United Kingdom do not understand the connection between weight issues and cancer.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
Olaparib, a new type of experimental drug called a PARP inhibitor, has shown promising results against inherited forms of breast and ovarian cancer in two small clinical trials led by scientists at the Breakthrough Breast Cancer Research Unit at King's College London.
› Verified 1 days ago
News Archive
In response to the crisis caused by milk adulterated with melamine that affected thousands of children in 2008, the International Dairy Federation and the International Organization for Standardization developed a technical specification/reviewed method : ISO/TS 15495 | IDF/RM 230:2010, Milk, milk products and infant formulae - Guidelines for the quantitative determination of melamine and cyanuric acid by LC-MS/MS.
A new study published in the Journal of Public Health has shown that the majority of people in the United Kingdom do not understand the connection between weight issues and cancer.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
Olaparib, a new type of experimental drug called a PARP inhibitor, has shown promising results against inherited forms of breast and ovarian cancer in two small clinical trials led by scientists at the Breakthrough Breast Cancer Research Unit at King's College London.
› Verified 1 days ago
Bradley Medical Equipment Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1800 S Lee Hwy, Cleveland, Tennessee 37311 Phone: (423) 472-4300 | |
Central Drug Co Type: Community/Retail Pharmacy Location: 100 Keith St Sw, Cleveland, Tennessee 37311 Phone: (423) 476-4597 | |
Central Drug Co Peerless Crossing Type: Community/Retail Pharmacy Location: 1075 Peerless Xing Nw, Cleveland, Tennessee 37312 Phone: (423) 339-3363 | |
Cherokee Medical Supply Type: Home Infusion Therapy Pharmacy Location: 1690 25th St. Nw, Cleveland, Tennessee 37311 Phone: (423) 559-3010 | |
Cleveland Optical Dispensary Inc Type: Eyewear Supplier (Equipment, not the service) Location: 2415 Chambliss Ave, Cleveland, Tennessee 37311 Phone: (423) 479-4397 |